Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bárbara Valera-Bestard"'
Autor:
Juan A. Pineda, Alicia Gutierrez-Valencia, Julián Torre-Cisneros, Mercedes González-Serrano, José A. Mira, Ignacio Santos, José A. Girón-González, Bárbara Valera-Bestard, Ana Arizcorreta-Yarza, Luis F. López-Cortés, Salvador Vergara, Juan Macías
Publikováno v:
Scopus-Elsevier
Introduction The clinical applicability of early viral kinetics at week 4 in predicting sustained virological response (SVR) of pegylated interferon (peg-IFN) plus ribavirin (RBV) in HIV/HCV-coinfected patients is unclear. Our objective was to determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bfa1ef57ef9b3c7010d2cd23b588f4a
https://doi.org/10.1177/135965350701200412
https://doi.org/10.1177/135965350701200412
Autor:
Bárbara Valera-Bestard, Mercedes González-Serrano, José A. Girón-González, Juan A. Pineda, José A. Mira, Antonio Rivero, Raquel Carrillo-Gómez, Antonio Collado, Jesús Gómez-Mateos, Luis F. López-Cortés, José A. García-García, Dolores Merino, Ignacio Gil, María J. Ríos-Villegas
Publikováno v:
The Journal of antimicrobial chemotherapy. 60(6)
Objectives: To investigate whether concomitant antiretroviral therapy (ART) is a predictor of sustained virological response (SVR) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients treated with pegylated interferon plu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15f7db1f42951dca8d51480040c8384
https://pubmed.ncbi.nlm.nih.gov/17938129
https://pubmed.ncbi.nlm.nih.gov/17938129
Autor:
Mercedes González-Serrano, Manuel Torres-Tortoso, Bárbara Valera-Bestard, Antonio Collado, Juan Macías, Antonio Rivero, Elisa Fernández-Fuertes, José A. Mira, José A. Girón-González, María J. Ríos-Villegas, Ana Arizcorreta-Yarza, Fernando Lozano, Juan A. Pineda, Luis F. López-Cortés, Dolores Merino
Publikováno v:
Scopus-Elsevier
BackgroundHaematological adverse events related to pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy could affect the patients’ quality of life; however, the risk factors for severe haematological toxicity associated with this therapy in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3badee5b5c65c1237811f49020da61a7
http://www.scopus.com/inward/record.url?eid=2-s2.0-38049079654&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-38049079654&partnerID=MN8TOARS
